Alex Vesia
-
On July 13, 2025, the Dodgers defeated the Giants 5-2 in eleven innings, with standout performances from Yamamoto and Freeman contributing to the win.
-
Saturday, July 12, 2025 Copyrighted by Sarah Morris, 2025 On a beautiful Saturday afternoon at Oracle Park, the Los Angeles Dodgers snapped their seven-game losing streak by edging out the San Francisco Giants 2-to-1. Shohei Ohtani, Emmet Sheehan, Alex Vesia, and Tanner Scott were brilliant. The Dodgers just got enough offense to win! Shohei Ohtani…
-
Friday, June 27, 2025 Copyrighted by Sarah Morris, 2025 On a picturesque Friday night at Kaufman Stadium, the Los Angeles Dodgers beat the Kansas City Royals 5-to-4. While Dustin May didn’t have it, the bullpen held the light-hitting Royals. Shohei Ohtani had a solo shot to start the game, and Max Muncy had a two-run…
-
The Dodgers secured an 11-7 victory over the Nationals, enhancing their division lead significantly.
-
On June 20, 2025, the Dodgers defeated the Nationals 6-5, supported by Kershaw’s strong pitching and key contributions from Hernández and Rojas, maintaining their division lead.
-
Shohei Ohtani returned after 663 days to lead the Dodgers to a 6-3 victory over the Padres, showcasing strong pitching and hitting performances.
-
The Dodgers’ pitchers and catchers held their first workout, but Michael Kopech’s forearm inflammation raises concerns, while Evan Phillips faces significant injury risks. With additional injuries, they signed Tanner Scott and Kirby Yates to bolster their bullpen depth.
-
The Dodgers signed Kirby Yates to bolster their bullpen as they face potential injuries among other relievers, aiming for another World Series title in 2025.
-
The Los Angeles Dodgers signed elite reliever Tanner Scott to a four-year, $72 million deal. With a strong bullpen including Scott, Treinen, and emerging rookies, they aim for continued success.
-
The Dodgers announced their World Series roster, adding Rojas, Vesia, and Graterol, while losing Phillips to injury. Rojas seeks to play despite surgery, while Vesia and Graterol face health challenges as well.
